USPTO Examiner MOEHLMAN ANDREW TERRY - Art Unit 1655

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19205994SYSTEM FOR INDUCING MUTATION BASED ON OPTIMIZED ACTIVATION-INDUCED CYTIDINE DEAMINASEMay 2025December 2025Allow710NoNo
19027003DIOXYGENASE MUTANTS AND USE THEREOF IN SYNTHESIZING (2S,3R)-3-HYDROXYPIPECOLIC ACIDJanuary 2025August 2025Allow711YesNo
19005323PREPARATION METHOD FOR BIOSYNTHESIS OF HUMAN BODY STRUCTURAL MATERIALDecember 2024December 2025Allow1211YesNo
18942174PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIANovember 2024May 2025Allow610NoNo
18917986COMPOSITIONS AND METHODS FOR ACCELERATING DEVELOPMENT OF CANCER THERAPEUTICSOctober 2024November 2025Abandon1310NoNo
18813643ENGINEERED MCP PROTEINS AND SYSTEMS THEREOFAugust 2024January 2026Allow1721NoNo
18665356LACTIPLANTIBACILLUS PLANTARUM EL6 FOR INCREASING FLAVONOID CONTENT, AND USE THEREOFMay 2024January 2026Abandon2021NoNo
18212190METHOD FOR PREPARING AGENT FOR PREVENTION OF HAIR LOSS AND PROMOTION OF HAIR REGROWTH THROUGH FUSION FERMENTATION OF LACTIC ACID BACTERIAJune 2023February 2026Allow3210NoNo
18300634ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERSApril 2023February 2026Allow3410NoNo
18133912METHOD FOR PRODUCING POLY(3-HYDROXYALKANOATE)April 2023December 2025Allow3210NoNo
18120528PSEUDOMONAS CHLORORAPHIS SPECIES AND ITS USE IN THE CONTROL OF FISH DISEASES CAUSED BY BACTERIA AND FUNGIMarch 2023June 2024Allow1510YesNo
17620528BROAD-SPECTRUM PEPTIDE ANTIGEN OF THE NOVEL CORONAVIRUS SARS-COV-2, SPECIFIC NEUTRALIZING ANTIBODY AND USE THEREOFDecember 2022March 2026Allow5111NoNo
18000986INSULIN DEGLUDEC DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOFDecember 2022February 2026Abandon3801NoNo
17926603METHOD OF TREATING OR PREVENTING AN INFECTIONNovember 2022January 2026Abandon3801NoNo
17925333Antiviral AgentNovember 2022January 2026Allow3811YesNo
17985033Engineered Enzymes and Method for the Synthesis of Diverse Tyrosine AnalogsNovember 2022October 2024Allow2311YesNo
17822349Plant Endophytic Bacteria And Methods To Control Plant Pathogens And PestsAugust 2022March 2026Abandon4211NoNo
17759918HETEROLOGOUS PROTEINS WITH AXONEMAL PROTEINSAugust 2022February 2026Allow4311YesNo
17795819BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOMEJuly 2022March 2026Allow4411YesNo
17858496USE OF NEUTRAL pH MOBILE PHASES IN REVERSED PHASE CHROMATOGRAPHY OF ACIDIC PEPTIDESJuly 2022January 2026Allow4231YesNo
17834149METHOD FOR PRODUCING GALACTOOLIGOSACCHARIDESJune 2022March 2024Allow2210YesNo
17730163PEA PEPTIDE WITH AUXILIARY HYPOGLYCEMIC FUNCTION AND PREPARATION METHOD THEREOFApril 2022October 2025Allow4121NoNo
17715841SAMPLE ANALYZER AND SAMPLE ANALYSIS METHODApril 2022November 2024Allow3111YesNo
17762912Method for Manufacturing Protein Fiber, Method for Manufacturing Protein Fiber Fabric, and Shrink-Proofing Method for Protein FiberMarch 2022November 2025Abandon4411NoNo
17761052CELL-COMPATIBLE TISSUE CLARIFYING COMPOSITIONMarch 2022October 2025Abandon4320NoNo
17642635DIRECTED EVOLUTION FOR OBTAINING IMPROVED VARIANTS OF TEV PROTEASE FOR BIOTECHNOLOGICAL APPLICATIONSMarch 2022November 2025Allow4511YesNo
17574459SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTUREJanuary 2022September 2024Abandon3311NoNo
17620491CELL CULTURE SUBSTRATE, METHOD FOR MANUFACTURING THE SAME AND SCREENING METHOD BY USING THE SAMEDecember 2021February 2025Abandon3801NoNo
17533850CELL PICKING DEVICE AND CELL PICKING METHODNovember 2021July 2025Allow4440YesNo
17518395RENAL TUBE ASSAY DEVICE AND METHODS OF MANUFACTURE AND USENovember 2021December 2024Allow3811YesNo
17607185A METHOD FOR RECOMBINANT PROTEIN PRODUCTIONOctober 2021May 2025Abandon4310NoNo
17604722OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDSOctober 2021April 2025Abandon4211NoNo
17497894LACTIC ACID BACTERIA, AND FEED, FERTILIZERS, AND LIVE BACTERIAL PREPARATIONS CONTAINING THE SAMEOctober 2021July 2024Abandon3310NoNo
17497895LACTIC ACID BACTERIA, AND FEED, FERTILIZERS, AND LIVE BACTERIAL PREPARATIONS CONTAINING THE SAMEOctober 2021July 2024Abandon3410NoNo
17496919MICROBIAL HYPERSWARMERS AND USES THEREOFOctober 2021May 2024Allow3111NoNo
17602317METHODS AND SYSTEMS FOR STABILIZATION AND PRESERVATION OF MICROBESOctober 2021January 2025Abandon4011NoNo
17489778System and Method of Induced Mutant Protein Based on Activation-induced Cytidine DeaminaseSeptember 2021September 2025Abandon4711NoNo
17598747METHOD FOR INHIBITING MICROBIAL CLOGGING IN DRIP IRRIGATORSSeptember 2021September 2024Allow3620YesNo
17482614Thermophilic Recombinant Type II Pullulanase and Application thereofSeptember 2021January 2025Allow4031YesNo
17480177BIOSYNTHETIC PRODUCTION OF GAMMA- AND DELTA-LACTONES USING CYTOCHROME P450 ENZYMES HAVING SUBTERMINAL HYDROXYLASE ACTIVITYSeptember 2021May 2025Allow4420YesNo
17439990FUSION PROTEINS, RECOMBINANT BACTERIA, AND EXOSPORIUM FRAGEMENTS FOR PLANT HEALTHSeptember 2021September 2025Abandon4811NoNo
17475423Method for anti-felting finishing of wool fabric with protease KSeptember 2021May 2025Abandon4411NoNo
17437424METHOD FOR OBTAINING AND PRESERVING HIGH-PURITY GROWTH FACTORS AND USES THEREOFSeptember 2021May 2025Abandon4410NoNo
17436847MIXTURE OF PROBIOTIC BACTERIA STRAINS FOR USE IN THE TREATMENT OF ALLERGIC ASTHMA AND WITH RECURRENT WHEEZING, PREFERABLY IN PAEDIATRIC SUBJECTSSeptember 2021February 2025Allow4111YesNo
17464019PHAGE DERIVED ANTIMICROBIAL ACTIVITIESSeptember 2021June 2024Abandon3401NoNo
17427295STABILIZATION OF NADPH OR NADH IN AMMONIA DETECTION ASSAYSJuly 2021December 2025Allow5321YesNo
17384039METHODS FOR TREATING INFECTIOUS DISEASESJuly 2021September 2024Abandon3711NoNo
17423861Method for Treating and/or Preventing Bacteriophage Lysis During FermentationJuly 2021February 2025Abandon4310NoNo
17418822Use of Peanut Hearts as a Fermentation BiostimulantJune 2021June 2024Abandon3610NoNo
17415964NEW LACTIC ACID BACTERIAJune 2021January 2025Allow4211YesNo
17344566COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOFJune 2021October 2024Abandon4101NoNo
17312013LEUCONOSTOC CITREUM AND USE THEREOF IN PRECIPITATING STARCH EMULSIONJune 2021June 2024Allow3620YesNo
17311707ULTRALOW CONCENTRATION SENSING OF BIO-MATTER WITH PEROVSKITE NICKELATE DEVICES AND ARRAYSJune 2021March 2025Allow4511YesNo
17338596BIOPOLYMER FILM AND METHOD OF PREPARING THE SAMEJune 2021April 2025Allow4640YesNo
17058612OVEREXPRESSION OF FUMARATE REDUCTASE RESULTS IN AN INCREASED FERMENTATION RATE IN YEASTMay 2021September 2024Allow4610YesNo
17293891USE OF TYPE I AND TYPE II POLYKETIDE SYNTHASES FOR THE PRODUCTION OF CANNABINOIDS AND CANNABINOID ANALOGSMay 2021September 2024Abandon4001NoNo
17302835WORKING ELECTRODE OF A CONTINUOUS BIOLOGICAL SENSORMay 2021March 2025Allow4611NoNo
17293407METHODS FOR DYNAMIC EVOLUTION AND MONITORING OF CHARACTERISTICS IN LIVING CELLS USING A MICROFLUIDIC-ENABLED MULTI-WELL CELL CULTURE DEVICES AND SYSTEMSMay 2021November 2024Allow4211YesNo
17292857METHOD OF PRODUCING HIGHER ALKANONES, PREFERABLY 6-UNDECANONE, AND DERIVATIVES THEREOFMay 2021September 2025Allow5240YesNo
17292676A METHOD FOR TESTING CELLULAR-LEVEL WATER CONTENT AND DISTRIBUTION IN FRUIT AND VEGETABLE TISSUES BASED ON RAMAN SPECTROSCOPYMay 2021December 2024Abandon4320NoNo
17292679COMBINED EXPRESSION OF TREHALOSE PRODUCING AND TREHALOSE DEGRADING ENZYMESMay 2021August 2025Abandon5121NoNo
17292302METHOD FOR MODIFYING THE GLYCOSYLATION PROFILE OF A RECOMBINANT GLYCOPROTEIN PRODUCED IN CELL CULTUREMay 2021September 2024Allow4120YesNo
17292358SYNERGISTIC BACTERIAL AND YEAST COMBINATIONSMay 2021December 2024Abandon4311NoNo
17291291METHOD FOR THE ENZYMATIC DEGRADATION OF POLYETHYLENE TEREPHTHALATEMay 2021July 2025Allow5130YesNo
17307877METHODS OF PRODUCING TWO CHAIN PROTEINS IN PROKARYOTIC HOST CELLSMay 2021January 2025Allow4411NoNo
17246266Subtilase Variants And Polynucleotides Encoding SameApril 2021January 2026Allow5631YesNo
17289177ALGAL OIL WITH IMPROVED NUTRITIONAL VALUEApril 2021October 2024Allow4210YesNo
17288211MEANS AND METHODS FOR DETERMINING METABOLIC ADAPTATIONApril 2021November 2024Abandon4301NoNo
17309080PRETREATMENT OF SOFTWOODApril 2021July 2024Abandon3910NoNo
17287227PROCESS FOR ENZYMATIC HYDROLYSIS OF CARBOHYDRATE MATERIAL AND FERMENTATION OF SUGARSApril 2021July 2024Abandon3901NoNo
17236705TARGET SUBSTANCE SEPARATION METHOD AND QUANTIFICATION METHODApril 2021July 2024Allow3911YesNo
17287240ENZYMATIC PRODUCTION OF HEXOSESApril 2021September 2024Allow4110YesNo
17236255AUTOMATIC PROCESSING DEVICE FOR LIQUID SAMPLESApril 2021December 2024Allow4420YesNo
17282513METHOD FOR STIMULATING THE GROWTH OF A BIOMASS, CONTAINED IN A LIQUID, INSIDE A BIOREACTORApril 2021January 2025Allow4520YesNo
17281952USE OF RECOMBINANT ANTIBACTERIAL PROTEIN ABLYSIN FOR EFFECTIVELY KILLING MULTIDRUG-RESISTANT PATHOGENIC BACTERIAMarch 2021August 2024Allow4011YesNo
17217706PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIAMarch 2021May 2024Allow3810YesNo
17278383SURFACE-MODIFIED CELLS, METHODS OF MAKING AND USINGMarch 2021August 2024Abandon4101NoNo
17277256LIVING MAMMALIAN CELLS MODIFIED WITH FUNCTIONAL MODULAR NANOPARTICLESMarch 2021November 2024Allow4411YesNo
17277260ARMORED CELLSMarch 2021April 2025Abandon4921NoNo
17274377Baicalein- and Scutellarein- Synthesizing Microorganism, Preparation Method and Applications ThereofMarch 2021April 2025Allow4921NoNo
17273397DETERGENT COMPOSITIONS AND USES THEREOFMarch 2021January 2024Abandon3401NoNo
17192751D-Glucaric Acid Producing Bacterium, and Method for Manufacturing D-Glucaric AcidMarch 2021December 2024Allow4620NoNo
17270220COMPOSITIONS COMPRISING A LIPOLYTIC ENZYME VARIANT AND METHODS OF USE THEREOFFebruary 2021March 2025Abandon4901NoNo
17270095PROTEIN-BASED ADHESIVE AND ITS MODIFICATIONFebruary 2021February 2025Allow4821YesNo
17181091APPARATUS FOR MONITORING BIOAEROSOLS AND METHOD THEREOFFebruary 2021December 2024Allow4520YesNo
17269100SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENTFebruary 2021December 2025Allow5821NoNo
17267168FIXATIVE SOLUTION AND METHOD OF PREPARATION OF BIOLOGICAL SAMPLEFebruary 2021December 2025Allow5831YesNo
17154431DISCRIMINATING PARKINSON'S DISEASE FROM MULTIPLE SYSTEM ATROPHY USING ALPHA-SYNUCLEIN PMCAJanuary 2021March 2024Abandon3710NoNo
17143731ERYTHROCYTE-BINDING THERAPEUTICSJanuary 2021September 2023Allow3300YesNo
16973738DIRECT MEASUREMENT OF IMMUNE SYSTEM RADIOSENSITIVITY AND RADIOTHERAPY TREATMENT PLAN OPTIMIZATIONDecember 2020April 2025Abandon5220YesNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner MOEHLMAN, ANDREW TERRY - Prosecution Strategy Guide

Executive Summary

Examiner MOEHLMAN, ANDREW TERRY works in Art Unit 1655 and has examined 64 patent applications in our dataset. With an allowance rate of 56.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.

Allowance Patterns

Examiner MOEHLMAN, ANDREW TERRY's allowance rate of 56.2% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by MOEHLMAN, ANDREW TERRY receive 1.36 office actions before reaching final disposition. This places the examiner in the 20% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MOEHLMAN, ANDREW TERRY is 43 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +76.1% benefit to allowance rate for applications examined by MOEHLMAN, ANDREW TERRY. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 35.0% of applications are subsequently allowed. This success rate is in the 78% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 83.3% of cases where such amendments are filed. This entry rate is in the 97% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.